Results
Aarti Drugs Q4 FY26 Revenue Rises 6% YoY to INR721 Cr
Aarti Drugs reported Q4 FY26 consolidated revenue of INR721.1 crores, up 6% YoY and 20% QoQ, with EBITDA at INR96.6 crores.
The company highlighted a sharp sequential recovery driven by stabilizing AP
